This study demonstrates an increase in expression of pro-angiogenic proteases and VEGFA in omental tissue with metastasized EOC compared to control omentum. Specifically, we show for the first time that omentum with metastatic disease has significantly increased endothelial expression of MMP9, CL, and VEGFA and mesothelial expression of CD, MMP9, and VEGFA. Further analysis

indicated that high omental mesothelial and endothelial expression of MMP9 and VEGF and high mesothelial expression of CD is associated with decreased DSS and/or OS in EOC. Most importantly, high omental endothelial MMP9 expression together with the presence of ascites predicts poor prognosis. MMPs and cathepsins have been implicated in tumor progression and have been widely investigated Cabozantinib mouse in cancers showing overexpression of these proteases,

including ovarian cancer [22], [23], [24] and [25]. Similarly, altered expression of pro-angiogenic factors such as VEGFA has been investigated in ovarian cancer, since angiogenesis is known to correlate with prognosis [10] and [26]. Importantly, ovarian cancer–secreted CD, CL, and MMP9 have been shown to regulate a range of cellular responses of omental microvascular endothelial cells in in vitro studies, highlighting their role as key alternative angiogenic mediators during omental progression of EOC [27]. Our data support selleck chemical these previous studies since the metastasized EOC cells were strongly immunoreactive for MMP9 and VEGFA and moderately for CD and CL. However, little or no expression of MMP2 was observed, in contrast to a previous study by Schmalfeldt et al. [28]. In addition to the expected expression of pro-angiogenic factors in the metastasized EOC, our study is the first

to specifically show overexpression of MMPs, cathepsins, and VEGFA Adenosine triphosphate in the endothelium and mesothelium of the omental tissue surrounding EOC metastases. These factors are likely to have a close pro-angiogenic relationship since protease degradation/remodeling of the ECM during angiogenesis can release pools of ECM-bound growth factors (i.e., VEGFA and basic fibroblast growth factor) that facilitate new vessel growth [7] and [29]. Importantly, our data suggest that the dissemination of EOC may engage a “cellular triangle” involving cancer cells (primary invaders and switchers of the microenvironment), endothelial cells (mediators of tumor-induced angiogenesis), and mesothelial cells (signal disseminators). Thus, invasion of the omentum by EOC is associated with pro-angiogenic protein expression in the surrounding omental tissue creating a microenvironment conducive to metastatic growth and disease progression. It is not possible to conclude from our data whether this is driven by the cancer cells, the endothelial/mesothelial cells, or a feedback loop between all three cell types “feeding” metastasis growth.